Tortugas Neuroscience
PrivateLast Round
Seed
Apr 21, 2026
Total Funding Raised
$106M
Company Overview
Tortugas Neuroscience is a neurology-focused biotech company that develops medicines to address diseases of the brain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Mental Health
Business Model
B2B
Customer Profile
Revenue Share, Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tortugas Neuroscience Comps
Public and private peers based on sector, stage, and business model.
Tortugas Neuroscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 21, 2026 |
Tortugas Neuroscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Seed |
| AN Venture Partners | Seed |
| Cure Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
$106M round closed
Tortugas Neuroscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tortugas Neuroscience's valuation, stock price, and market status.
